Syncronis HPLC columns deliver greater consistency

Published: 15-Sep-2010
Manufacturing

Every column is individually tested, says Thermo Fisher

Syncronis HPLC columns deliver greater consistency
Thermo Fisher Scientific’s new Syncronis HPLC columns deliver consistent, predictable separations, from run to run and column to column.

The company says the range delivers exceptional reproducibility by providing highly pure, high surface-area silica, dense bonding and double end-capping.

Enhanced, automated column packing methods used within the Syncronis range assist in delivering greater consistency, and every column is individually tested to ensure that it meets the required specifications, the firm says.

Syncronis columns are available with 5µm particle size for conventional HPLC applications and with 1.7µm particle size for high-speed, high-efficiency UHPLC separations.

  • Companies:
  • Thermo Fisher Scientific
See more

You may also like

Manufacturing
Thermo Fisher Scientific launches new general purpose centrifuges with natural refrigerant cooling

Thermo Fisher Scientific launches new general purpose centrifuges with natural refrigerant cooling

Read more
New X2 and S2 Series centrifuges combine precise performance with improved sustainability for research, biopharma and clinical laboratories

Trending Articles

  1. DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction The pair will combine DNA Script's EDS technology with GE HealthCare's DNA scaling technology to create a faster, more flexible manufacturing process for cell-free DNA as the use of personalised and time-sensitive genetic medicines grows
  2. FDA escalates action against Dabur India over systemic data-integrity and cGMP failures The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process validation and weaknesses in quality-unit oversight, saying the company's response failed to address the systemic nature of the deficiencies
  3. Thermo Fisher Scientific launches new general purpose centrifuges with natural refrigerant cooling New X2 and S2 Series centrifuges combine precise performance with improved sustainability for research, biopharma and clinical laboratories
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Portable gas detection in the pharmaceutical sector Gas safety is a critical consideration in the pharmaceutical sector. Hazardous gases and airborne contaminants are common by-products of manufacturing processes … and employers must control worker exposure in accordance with relevant legislation and industry standards
  5. Complex APIs demand a new generation of CDMO partnerships Modern API complexity and geopolitical pressures are driving deeper, integrated sponsor–CDMO partnerships built on early scientific alignment, resilient supply, and manufacturable routes

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Manufacturing
Thermo Fisher Scientific launches new general purpose centrifuges with natural refrigerant cooling

Thermo Fisher Scientific launches new general purpose centrifuges with natural refrigerant cooling

New X2 and S2 Series centrifuges combine precise performance with improved sustainability for research, biopharma and clinical laboratories
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
The invisible advantage: how rigour fuels reliability in drug development

The invisible advantage: how rigour fuels reliability in drug development

Far from being a compliance checkbox, quality is the decisive factor that separates consistent process optimisation from costly setbacks
Manufacturing
Thermo Fisher's Patheon becomes exclusive third-party CDMO for KinetiSol technology

Thermo Fisher's Patheon becomes exclusive third-party CDMO for KinetiSol technology

The agreement will install KinetiSol Formulator equipment across Patheon's Bend and Cincinnati OSD sites, offering pharma customers an integrated development-to-commercial pathway for poorly soluble drug candidates
Manufacturing
Thermo Fisher and SHL Medical collaborate to integrate autoinjector assembly with sterile fill-finish at Ridgefield site

Thermo Fisher and SHL Medical collaborate to integrate autoinjector assembly with sterile fill-finish at Ridgefield site

The duo will integrate the SHL's Molly autoinjector platform into Thermo's Ridgefield, New Jersey facility, creating an end-to-end US-based solution for drug-device combination products spanning sterile manufacturing, device assembly and commercial packaging
Manufacturing
Thermo Fisher unveils HepatoExpress kit for liver cell gene expression analysis

Thermo Fisher unveils HepatoExpress kit for liver cell gene expression analysis

The new Invitrogen TaqMan Cells-to-CT HepatoExpress Kit eliminates the need for traditional RNA purification, streamlining workflows and reducing time to results and offers less plastic waste compared to traditional RNA purification methods
Manufacturing
Thermo Fisher Scientific Expands Gibco Bacto portfolio

Thermo Fisher Scientific Expands Gibco Bacto portfolio

Its next-generation, chemically defined media will boost E. coli biomanufacturing productivity, helping innovators scale plasmid DNA and protein production with confidence
Manufacturing
Thermo Fisher Scientific doubles down on investment in Asia

Thermo Fisher Scientific doubles down on investment in Asia

New and expanded Bioprocess Design Centres will provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region
Subscribe now